Ahead-of-Print
Review
-
Chimeric antigen receptor therapy for hematological malignancies: a pediatric perspective from leukapheresis to infusion
-
When is ABO-incompatible plasma safe to transfuse? Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products
-
Combination of Evans syndrome and COVID-19: a systematic review of reported cases
-
The Red Blood Cell-Improving Transfusions for Chronically Transfused Recipients (RBC-IMPACT) study: protocol description of an international multi-site observational clinical study
-
Platelet rich plasma for assisted reproduction: an overview of systematic reviews
Original article
-
Exploring Italians’ knowledge of, and perceptions and feelings about stem cell donation: a GITMO-IBMDR nationwide survey
-
Effectiveness of oral platelet lysate gel to treat oral mucosal manifestations associated with chronic graft versus host disease
-
Impact of leukoreduction on the metabolome of ovine packed red blood cells during refrigerated storage
-
Partial s antigen expression in GP(B-A-B) hybrid glycophorins and the corresponding in vitro expression study
-
Pilot study of ABO-isogroup or universal plasma pools with or without pathogen reduction treatment
-
The impact of red cell storage age on transfused patients with sickle cell disease: protocol of a pilot randomized clinical trial to evaluate changes in inflammation and clinical transfusion efficacy
-
First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial
-
Patient Blood Management in pediatric and adolescent bone marrow donors: results from an Italian survey
-
The tandem CD33-CLL1 CAR-T as an approach to treat acute myeloid leukemia
Brief report
-
Hemostasis testing practices vary in patients with high bleeding risk undergoing therapeutic plasma exchange
-
Thrombophilia screening of related hematopoietic stem cell donors before collection: results of a single-center activity
-
Real world analysis of long-term efficacy of isovolemic red cell exchange in sickle cell disease: a single center experience